TheStreet is reporting that investors bid up Mylan's stock after the pharmaceutical company settled with the U.S. Department of Justice.
Here's what you need to know.
1. Before market open Monday, the stock jumped 12 percent hitting $35.94 a share.
2. After the market opened, the stock jumped 10 percent to $39.49 a share.
3. Mylan is still being investigated by the Minnesota and New York Attorney Generals.
4. Randall Stanicky, an analyst with RBC Capital Markets said the company's stock will decrease in the coming weeks.
More coding, billing and collections news:
6 things to know about what the government is doing to people who lost coverage through the ACA
Mylan agrees to pay $465M in settlement with feds: 8 notes
Repeal it or fix it? 2nd presidential debate fires up with ACA debate